Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.
Status:
Completed
Trial end date:
2003-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine wich treatment is the most effective in prevention
of glucocorticoid-induced osteoporosis in patients with rheumatic diseases. The STOP-study: a
randomized placebo controlled trial with alendronate versus alfacalcidol.
Phase:
Phase 3
Details
Lead Sponsor:
UMC Utrecht
Collaborator:
Dutch Health Care Insurance Board
Treatments:
Alendronate Alfacalcidol Glucocorticoids Hydroxycholecalciferols Vitamin D